Melanoma Perspective

• Topics Cardiologists Love to Hate: MOC and AI   Bob Harrington and Mike Gibson discuss two of the hottest topics in cardiology and medicine for 2023: a proposed alternative to the maintenance of certification process, and artificial intelligence.
  theheart.org on Medscape, December 29, 2023
• MOC: An 'Insult to Oncologists' Engaged in Patient Care   Dr Mark Lewis discusses why lifelong learning is essential to the day-to-day practice of oncologists.
  Medscape Oncology, November 07, 2023
• Melanoma Updates From ASCO 2023: PD-1 and LAG-3   Jeffrey S. Weber, MD, PhD, discusses updates related to melanoma practice and care from ASCO 2023.
  Medscape Oncology, October 24, 2023
• Episode 6: Managing Myasthenia Gravis in Primary Care: Best Practices   Drs Nicholas Silvestri and Michael Hehir discuss best practices for primary care physicians who see patients with myasthenia gravis.
  Medscape, October 24, 2023
• Episode 6: The Management of Melanoma in Community Oncology Practice   Drs Patel, Wright, and Devoe revisit their involvement in the SWOG S1801 trial to highlight available resources that can expand the reach of cancer care in the community oncology setting.
  Medscape, October 18, 2023
• Episode 5: Melanoma: Survivorship, Surveillance, and Follow-up   Five years, 7 years, or 10 years: How long should follow-up last in melanoma? Dr Sapna Patel and Professor James Larkin discuss the challenges and opportunities.
  Medscape, September 19, 2023
• Episode 6: The Future of CAR T-cell Therapy   Join Drs Amelia Langston and Frederick Locke as they discuss the future of CAR T-cell therapy research and treatment.
  Medscape, September 12, 2023
• Episode 4: Liquid Biopsy in Melanoma   Drs Sapna Patel and David Polsky explore biomarker development and the clinical utilization of liquid biopsy in melanoma.
  Medscape, August 17, 2023
• Episode 3: What's New and What's Making a Splash in the Melanoma Space   Drs Sapna P. Patel and Kim A. Margolin sift through the data from studies presented at recent conferences, including the KEYNOTE-942 and RP1 IGNYTE studies.
  Medscape, July 18, 2023
• Episode 2: Choosing Frontline Treatment for Metastatic Melanoma   Drs Sapna Patel and Yana Najjar analyze the data and share their approach to frontline therapy.
  Medscape, June 15, 2023
• Episode 1: The Role of Adjuvant and Neoadjuvant Therapy in Melanoma   Drs Sapna Patel and Matteo Carlino dive into the data and consider the current and future roles of adjuvant and neoadjuvant therapy.
  Medscape, June 15, 2023
• Episode 1: When Is CAR T-Cell Therapy the Answer?   Drs Amelia Langston and Melody Smith provide an overview of CAR T-cell therapy, the products available, potential complications, and what's next in this rapidly advancing field.
  Medscape, May 11, 2023
• ACMS 2023 Read clinically focused news coverage of key developments from ACMS 2023
  Medscape Dermatology, May 08, 2023
• Society for Melanoma Research 2022: Adjuvant and TIL Therapy   Jeffrey S. Weber, MD, PhD, discusses abstracts presented at the recent Society for Melanoma Research meeting in Edinburgh, Scotland.
  Medscape Oncology, March 03, 2023
• Neoantigen Vaccine With Pembrolizumab Has Clear Benefit in Melanoma   Jeffrey S. Weber, MD, PhD, discusses recently released data on a new antigen vaccine with pembrolizumab.
  Medscape Oncology, March 01, 2023
• More Guidance Needed for Cancer Screening in Rheumatology Karmela Kim Chan, MD, discusses new myositis cancer screening guidelines as a good starting point for future needed efforts to guide cancer screening in patients with rheumatic diseases.
  Hospital for Special Surgery, January 12, 2023
• 2022 in Review Through a Cardiology Lens   In part 1 of their annual review, cardiologists Bob Harrington and Mike Gibson discuss in-person meetings, wearables and AI, COVID lessons for medical research, and the growth of RCTs from China.
  theheart.org on Medscape, December 19, 2022
• AACR 2022 New Data for Melanoma Patients Who Progress After PD-1 Blockade   Dr Jeffrey Weber discusses potential new approaches to managing melanoma patients who progress after anti-PD-1 agents.
  Medscape Oncology, December 08, 2022
• Skin Cancer Exam in Primary Care: More Harm Than Good Dr Kenny Lin explains why he no longer conducts full-body skin cancer screening during wellness visits.
  Medscape Family Medicine, November 17, 2022
• A Gut Reaction: Making a Better Gut for a Better Response   Oncologists discuss research into altering the microbiome through fecal transplant or changes in diet to improve tumor response to immune checkpoint inhibitors.
  Medscape TV, November 02, 2022